198 related articles for article (PubMed ID: 22426972)
1. Anti-HuC and -HuD autoantibodies are differential sero-diagnostic markers for small cell carcinoma from large cell neuroendocrine carcinoma of the lung.
Matsumoto T; Ryuge S; Kobayashi M; Kageyama T; Hattori M; Goshima N; Jiang SX; Saegusa M; Iyoda A; Satoh Y; Masuda N; Sato Y
Int J Oncol; 2012 Jun; 40(6):1957-62. PubMed ID: 22426972
[TBL] [Abstract][Full Text] [Related]
2. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites.
Manley GT; Smitt PS; Dalmau J; Posner JB
Ann Neurol; 1995 Jul; 38(1):102-10. PubMed ID: 7541976
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel.
Nitadori J; Ishii G; Tsuta K; Yokose T; Murata Y; Kodama T; Nagai K; Kato H; Ochiai A
Am J Clin Pathol; 2006 May; 125(5):682-92. PubMed ID: 16707368
[TBL] [Abstract][Full Text] [Related]
4. Detection of tumor-specific autoantibodies in sera of patients with lung cancer.
Nagashio R; Sato Y; Jiang SX; Ryuge S; Kodera Y; Maeda T; Nakajima T
Lung Cancer; 2008 Dec; 62(3):364-73. PubMed ID: 18485524
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of the HuD gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines.
Sekido Y; Bader SA; Carbone DP; Johnson BE; Minna JD
Cancer Res; 1994 Sep; 54(18):4988-92. PubMed ID: 8069866
[TBL] [Abstract][Full Text] [Related]
6. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas.
Takeuchi T; Minami Y; Iijima T; Kameya T; Asamura H; Noguchi M
Pathol Int; 2006 Aug; 56(8):434-9. PubMed ID: 16872437
[TBL] [Abstract][Full Text] [Related]
8. Significant high expression of cytokeratins 7, 8, 18, 19 in pulmonary large cell neuroendocrine carcinomas, compared to small cell lung carcinomas.
Nagashio R; Sato Y; Matsumoto T; Kageyama T; Satoh Y; Ryuge S; Masuda N; Jiang SX; Okayasu I
Pathol Int; 2010 Feb; 60(2):71-7. PubMed ID: 20398190
[TBL] [Abstract][Full Text] [Related]
9. [The value of specific neuronal anti-Hu antibody in the early diagnosis of small cell lung cancer].
Wang G; Chen Q; Zhu Y; Ke D; Qian W; Song W
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):732-5. PubMed ID: 12622892
[TBL] [Abstract][Full Text] [Related]
10. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung.
Ullmann R; Petzmann S; Sharma A; Cagle PT; Popper HH
Hum Pathol; 2001 Oct; 32(10):1059-63. PubMed ID: 11679939
[TBL] [Abstract][Full Text] [Related]
12. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma.
Hiroshima K; Iyoda A; Shibuya K; Haga Y; Toyozaki T; Iizasa T; Nakayama T; Fujisawa T; Ohwada H
Cancer; 2004 Mar; 100(6):1190-8. PubMed ID: 15022286
[TBL] [Abstract][Full Text] [Related]
14. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
15. Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability.
den Bakker MA; Willemsen S; Grünberg K; Noorduijn LA; van Oosterhout MF; van Suylen RJ; Timens W; Vrugt B; Wiersma-van Tilburg A; Thunnissen FB
Histopathology; 2010 Feb; 56(3):356-63. PubMed ID: 20459535
[TBL] [Abstract][Full Text] [Related]
16. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
[TBL] [Abstract][Full Text] [Related]
17. Expression of HuD (a paraneoplastic encephalomyelitis antigen) mRNA in lung cancer.
Cho JH; Noguchi M
J Korean Med Sci; 1997 Aug; 12(4):305-10. PubMed ID: 9288629
[TBL] [Abstract][Full Text] [Related]
18. Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitis.
Graus YF; Verschuuren JJ; Degenhardt A; van Breda Vriesman PJ; De Baets MH; Posner JB; Burton DR; Dalmau J
J Neuroimmunol; 1998 Mar; 82(2):200-9. PubMed ID: 9585817
[TBL] [Abstract][Full Text] [Related]
19. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.
Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S
J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482
[TBL] [Abstract][Full Text] [Related]
20. Large cell neuroendocrine carcinoma of the lung: a comparison with large cell carcinoma with neuroendocrine morphology and small cell carcinoma.
Peng WX; Sano T; Oyama T; Kawashima O; Nakajima T
Lung Cancer; 2005 Feb; 47(2):225-33. PubMed ID: 15639721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
